Report Published: "Egypt Pharmaceuticals & Healthcare Report Q1 2014"
The Egyptian drug authority's complex organisational structure - with various sub-organisations and committees - makes for a difficult drug registration process for local and foreign drugmakers. We also note that, despite a relatively sound intellectual property (IP) environment, compared to other Middle East and North African (MENA) countries, and a recently established international drug pricing referencing system in favour of multinationals, political instability will continue to deter foreign investment in the Egyptian pharmaceutical industry.
View full press release